Sign In

Login

Password

Forgot Password ? Sign Up

Mitomicina (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mitomicina" in Italian language version.

refsWebsite
Global rank Italian rank
29nih.gov
4th place
9th place
2oadoi.org
799th place
22nd place
2doi.org
2nd place
7th place

doi.org

dx.doi.org

nih.gov

ncbi.nlm.nih.gov

  • L. Denis, F. Keuppens; G. Hendrickx, Mitomycin C therapy in superficial bladder cancer., in Prog Clin Biol Res, 185B, 1985, pp. 113-22, PMID 3929269.
  • E. Kaasinen, E. Rintala; AK. Pere; J. Kallio; VM. Puolakka; T. Liukkonen; K. Tuhkanen, Weekly mitomycin C followed by monthly bacillus Calmette-Guerin or alternating monthly interferon-alpha2B and bacillus Calmette-Guerin for prophylaxis of recurrent papillary superficial bladder carcinoma., in J Urol, vol. 164, n. 1, Jul 2000, pp. 47-52, PMID 10840422.
  • D. Cordonnier, FC. Vert-Pré; F. Bayle; JL. Alix; P. Couderc, [Nephrotoxicity of mitomycin C (apropos of 25 case reports). Results of a multicenter survey organized by the Society of Nephrology]., in Nephrologie, vol. 6, n. 1, 1985, pp. 19-26, PMID 3923381.
  • VS. Neild, KV. Sanderson; PR. Riddle, Dermatitis due to mitomycin bladder instillations., in J R Soc Med, vol. 77, n. 7, Jul 1984, pp. 610-1, PMID 6235369.
  • MA. Arregui, A. Aguirre; N. Gil; J. Goday; JA. Ratón, Dermatitis due to mitomycin C bladder instillations: study of 2 cases., in Contact Dermatitis, vol. 24, n. 5, maggio 1991, pp. 368-70, PMID 1832619.
  • AC. de Groot, JM. Conemans, Systemic allergic contact dermatitis from intravesical instillation of the antitumor antibiotic mitomycin C., in Contact Dermatitis, vol. 24, n. 3, Mar 1991, pp. 201-9, PMID 1831098.
  • GB. Colver, JA. Inglis; E. McVittie; MJ. Spencer; DA. Tolley; JA. Hunter, Dermatitis due to intravesical mitomycin C: a delayed-type hypersensitivity reaction?, in Br J Dermatol, vol. 122, n. 2, Feb 1990, pp. 217-24, PMID 2138492.
  • SC. Gulati, P. Sordillo; S. Kempin; L. Reich; GB. Magill; E. Scheiner; B. Clarkson, Microangiopathic anemia observed after treatment of epidermoid carcinoma with mitomycin C and 5-fluorouracil., in Cancer, vol. 45, n. 9, maggio 1980, pp. 2252-7, PMID 7379025.
  • KY. Yeh, P. Dunn; JW. Chang; CC. Liaw, Microangiopathic hemolytic anemia in a patient with recurrent anal cancer and liver metastasis., in Chang Gung Med J, vol. 25, n. 10, Oct 2002, pp. 706-10, PMID 12518784.
  • KD. Lempert, Haemolysis and renal impairment syndrome in patients on 5-fluorouracil and mitomycin-C., in Lancet, vol. 2, n. 8190, Aug 1980, pp. 369-70, PMID 6105503.
  • JE. Cantrell, TM. Phillips; PS. Schein, Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy., in J Clin Oncol, vol. 3, n. 5, maggio 1985, pp. 723-34, PMID 3923162.
  • J. Jolivet, L. Giroux; S. Laurin; J. Gruber; P. Bettez; PR. Band, Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome., in Cancer Treat Rep, vol. 67, n. 5, maggio 1983, pp. 429-34, PMID 6406059.
  • CL. Claycomb, M. Berkovic, Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case., in J Am Osteopath Assoc, vol. 86, n. 8, Aug 1986, pp. 499-503, PMID 3093413.
  • DC. Linette, KH. McGee; JA. McFarland, Mitomycin-induced pulmonary toxicity: case report and review of the literature., in Ann Pharmacother, vol. 26, n. 4, Apr 1992, pp. 481-4, PMID 1576382.
  • Z. Wajsman, W. McGill; L. Englander; RP. Huben; JE. Pontes, Severely contracted bladder following intravesical mitomycin C therapy., in J Urol, vol. 130, n. 2, Aug 1983, pp. 340-1, PMID 6410085.
  • WC. Baker, MA. Russo; RW. deVere White, Severe bladder contracture in patient receiving intravesical mitomycin C for superficial bladder cancer., in Urology, vol. 30, n. 4, Oct 1987, pp. 357-8, PMID 3116739.
  • PC. Drago, RA. Badalament; J. Lucas; JR. Drago, Bladder wall calcification after intravesical mitomycin C treatment of superficial bladder cancer., in J Urol, vol. 142, n. 4, Oct 1989, pp. 1071-2, PMID 2507794.
  • JW. Hetherington, P. Whelan, Persistent ulcers after bladder instillation of mitomycin C., in Lancet, vol. 1, n. 8476, Feb 1986, p. 324, PMID 2868188.
  • JW. Hetherington, DW. Newling; MR. Robinson; PH. Smith; RS. Adib; P. Whelan, Intravesical mitomycin C for the treatment of recurrent superficial bladder tumours., in Br J Urol, vol. 59, n. 3, Mar 1987, pp. 239-41, PMID 3105631.
  • HH. Kim, C. Lee, Intravesical mitomycin C instillation as a prophylactic treatment of superficial bladder tumor., in J Urol, vol. 141, n. 6, Jun 1989, pp. 1337-9; discussion 1339-40, PMID 2498532.
  • H. Isbarn, L. Budäus; U. Pichlmeier; S. Conrad; H. Huland; MG. Friedrich, [Comparison of the effectiveness between long-term instillation of mitomycin C and short-term prophylaxis with MMC or bacille Calmette-Guérin. Study of patients with non-muscle-invasive urothelial cancer of the urinary bladder]., in Urologe A, vol. 47, n. 5, maggio 2008, pp. 608-15, DOI:10.1007/s00120-008-1671-z, PMID 18317718.
  • R. Järvinen, E. Kaasinen; A. Sankila; E. Rintala, Long-term efficacy of maintenance bacillus Calmette-Guérin versus maintenance mitomycin C instillation therapy in frequently recurrent TaT1 tumours without carcinoma in situ: a subgroup analysis of the prospective, randomised FinnBladder I study with a 20-year follow-up., in Eur Urol, vol. 56, n. 2, Aug 2009, pp. 260-5, DOI:10.1016/j.eururo.2009.04.009, PMID 19395154.
  • DL. Gustafson, JD. Swanson; CA. Pritsos, Role of xanthine oxidase in the potentiation of doxorubicin-induced cardiotoxicity by mitomycin C., in Cancer Commun, vol. 3, n. 9, Sep 1991, pp. 299-304, PMID 1911046.
  • F. Villani, R. Comazzi; G. Lacaita; A. Guindani; V. Genitoni; A. Volonterio; MC. Brambilla, Possible enhancement of the cardiotoxicity of doxorubicin when combined with mitomycin C., in Med Oncol Tumor Pharmacother, vol. 2, n. 2, 1985, pp. 93-7, PMID 3932789.
  • MP. Rivera, MG. Kris; RJ. Gralla; DA. White, Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy., in Am J Clin Oncol, vol. 18, n. 3, Jun 1995, pp. 245-50, PMID 7747713.
  • MG. Kris, D. Pablo; RJ. Gralla; MT. Burke; J. Prestifilippo; D. Lewin, Dyspnea following vinblastine or vindesine administration in patients receiving mitomycin plus vinca alkaloid combination therapy., in Cancer Treat Rep, vol. 68, n. 7-8, pp. 1029-31, PMID 6744336.
  • D. Luedke, TT. McLaughlin; C. Daughaday; S. Luedke; B. Harrison; G. Reed; O. Martello, Mitomycin C and vindesine associated pulmonary toxicity with variable clinical expression., in Cancer, vol. 55, n. 3, Feb 1985, pp. 542-5, PMID 3917366.
  • JA. Benvenuto, RW. Anderson; K. Kerkof; RG. Smith; TL. Loo, Stability and compatibility of antitumor agents in glass and plastic containers., in Am J Hosp Pharm, vol. 38, n. 12, Dec 1981, pp. 1914-8, PMID 7325172.
  • EJ. Quebbeman, NE. Hoffman; RK. Ausman; AA. Hamid, Stability of mitomycin admixtures., in Am J Hosp Pharm, vol. 42, n. 8, Aug 1985, pp. 1750-4, PMID 4036973.

oadoi.org